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Level of expression of E-cadherin mRNA in colorectal cancer correlates
with clinical outcome
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Cancer Research Fund, 44 lincoln's Inn Fields, London WC2A 3PX, UK.
A seris of coorta carcinomas (n
= 49) resected from patients with known chinical outcomes
were analysed for E-caderin expression using in situ hybridisation to measure mRNA. Patients surviving 5
years or longer (n = 31) exhibited significantly higher kvels of E-cadherin mRNA than those surviving less
than 5 years (n = 18, P = 0.003). These peiminary reslts from this small sample suggest that E-cadherin
expression may be a useful prognostic marker in colorectal cancer patients.
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Colorectal cancer is one ofthe most common malignances in
the developed world and remains a major publc health
problem (King's Fund Forum, 1990). Pathological staging,
using the Dukes claation, offers an accurate guide to the
outcome of patients who have undergone surgicl resection
(Deans et al., 1992, 1993). However, in Dukes stage B
category, many patients who putatively have had a curative
resection will succumb to metastasis or tumour recurr.
Identification of the lily prognostic outcome of any one
individual within this broad division would be of great use
but unfortunately remains impossible at this time.
E-cadherin is a member of the large cadherin family of
homophilic cell-cell adhesion molecules and is expressed in
all epithelial tissues (Takeichi, 1990). E-cadherin moleules
maintain intercellular connections and, importantly, par-
ticipate in signalling and communication between neighbour-
ing cells (Takeichi, 1990). Tbere is increasing evience that
E-cadherin plays a significant role in neoplastic behaviour.
For example, experimental studies have revealed that loss of
this mokcule from epithelial cells is associated with the
acquisition of the invasive phenotype (Vlminckx et al.,
1991). There appears, moreover, to be a quantitative correla-
tion between the level of E-cadherin expression and invasive
ability in a range of cell lines derived from human car-
cinomas (Frixen et al., 1991). A large number offresh human
cancers also have been analysed for E-cadherin expression by
immunohistochemistry (Takeichi, 1993), including clinical
material denved from patients with colorectal cancer (Dorudi
et al., 1993; Kinsella et al., 1993; Nigam et al., 1993).
Generally, these investigations have revealed an inverse rela-
tionship between E-cadherin expression and tumour grade,
with poorly differentiated tumours exhibiting reduced or
absent immunoreactivity (Takeichi, 1993). Although down-
regulation of E-cadherin has been observed in
undifferentiated (Dorudi et al., 1993; Kinsella et al., 1993;
Nigam et al., 1993) and advanced colorectal carcinomas
(Dorudi et al., 1993), no study has yet examined the possible
relationship between expression ofthis cell adhesion molecule
and prognosis in colorectal cancer. Such a relationship, how-
ever, has been exaied in three other tumour types: blad-
der, head and neck and gastric cancer (Brnguier et al., 1993;
Mattijsen et al., 1993; Mayer et al., 1993). Uniformly, these
authors all reported that a reduced level of E-cadherin was
correlated significntly with poor prognosis, but the studies
all used frozen material for E-cadherin immunohistochemis-
try, tended not to have stage-matched material and had
lmited follow-up data (of less than 5 years) (Bringuier et al.,
1993; Mattijsen et al., 1993; Mayer et al., 1993).
Previously we showed that in colorectal cancer there is a
good correlation between the presence of E-cadherin mRNA
and protein (Dorudi et al., 1993). Therefore, by using in situ
hybridisation of paraffin-embedded, archival material solely
from Dukes stage B cancers, we have now been able to
examine these relationships in tumours from patients with
extended follow-up periods. Although the 5 year survival rate
in this group is approximately 70%, identification of those
patients with a poor prognosis is of significant clinical and
epidemiological importance since 35% of all colorectal
cancers are Dukes stage B (Morson, 1990). We show here
that retrospective analysis of the relationship between E-
cadherin expression and survival in a series of Dukes B
colorectal carcnomas, resected from patients who had either
survived in excess of 5 years or succumbed to recurrent or
metastatic disease within 5 years of surgery reveals an
association between poor prognosis and reduced levels ofthis
adhesion molecule.
Materials and --oP
Patient selection
Formalin-fixed, paraffin-embedded tumours were obtained
from the archival store in the Department ofPathology at St.
Mark's HospitaL London, UK. The selection of these
tumours was made consecutively on a chronological basis as
long as the patients from whom these tumours were rescted
fufilled our criteria for this study. Thus, survivors (n = 31)
were defined as patients who had been followed up regularly
in out-patient cinic and were assessed clnially as disease-
free for a minimum of 5 years, while non-survivors (n = 18)
had died as a result of their malignancy within this time.
These patient data were obtained from the Research Records
Department at St. Mark's Hospital and concened patients
undergoing surgery during a 9 year period between 1970 and
1978.
In situ hybridisation
An antisense riboprobe was prepared from a SmaI digest of a
386 bp partial ECD cDNA (HC61) in a Bluescript SK vector
(generously provided by Professor W Birchmeier) by a T3
RNA polymerase, using 35S-labelled UTP (Amersham, UK).
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Hybndisation to the sections was performed essentially as
described by Senior et al. (1988). The tumours were graded
and evaluated for E-cadherin positivity using the following
scoring system: 3 + denoted a strong homogenous signal, 2+
indicated a clear signal that was heterogenous, 1+ was a
recognisable but weak signal, while 0 referred to negative
tumours. Examples of tumours scoring 1 + and 3+ are
shown in Figure 1. Normal epithelium was, wherever possi-
ble, used as an internal positive control (35 out of the 49
tumours examined). However, in every tumour the presence
of intact mRNA in all tissue compartments was assessed by
using a riboprobe, h"A-10, to detect A-actin mRNA (Ponte et
al., 1983) and tumours which did not exhibit a strong signal
for P-actin were excluded from the study. Tumours were
assessed by one of us (AMH) on two different occasions
separated by an interval of 2 weeks with a concordance of
over 95%. This observer remained unaware of the clinical
outcome of the patients from whom these tumours were
derived.
E-cadherin score in relation to tumour grade. Interestingly,
four of five (80%) poorly differentiated tumours scoring 3+
were resected from patients surviving more than 5 years.
Kaplan-Meier survival curves were also constructed for each
E-cadherin score, and these are shown in Figure 2. These
data were analysed using the log-rank test and found to be
significant (P = 0.001) with extended survival in patients
whose tumour E-cadherin scores were high (2+ or 3+).
Dis~
Unlike previous reports on the prognostic value of E-
cadherin expression (Bringuier et al., 1993; Mattijssen et al.,
1993; Mayer et al., 1993), this study has employed in situ
hybridisation to measure E-cadherin mRNA rather than the
assessment of protein by immunohistochemistry on frozen
material. Numerous studies have examined E-cadherin
Results
The E-cadherin scores and grades of tumours in the group of
5 year survivors as compared with those in the non-survivors
group are presented in Table I. There was a significant
difference in the levels of E-cadherin mRNA between sur-
vivors and non-survivors (Fisher's exact test, P= 0.003).
Table II reveals that 19 of 31 tumours (61%) in the survivors
group expressed an E-cadherin score of 3 +, while only 3 out
of 18 (17%) tumours from the non-survivors exhibited this
level of E-cadherin expression. Table III shows an analysis of
b
Table I Grade and
Survivors
Differentiation
Mod
Mod
Mod
Well
Mod
Mod
Mod
Mod
Mod
Well
Mod
Mod
Mod
Mod
Poor
Poor
Mod
Mod
Poor
Mod
Mod
Mod
Poor
Mod
Mod
Mod
Mod
Mod
Well
Mod
Mod
E-cadhenrn expression scores of individual
Dukes B tumours
Non-survivors
Grade Score
Wel 1+
Mod 2+
Mod 1+
Mod 2+
Mod 2+
Mod 0
Mod 3+
Mod 3+
Mod 2+
Mod 0
Mod 0
Mod 1+
Mod 2+
Poor 0
Poor 0
Mod 1+
Poor 3+
Mod 1+
Score
2+
2+
2+
0
1+
3+
3+
3+
2+
2+
2+
1+
1+
3+
3+
3+
3+
3+
3+
3+
3+
2+
3+
3+
3+
3+
2+
3+
3+
3+
3+
Mod, moderately differentiated.
Table I Summary of E-cadherin scores in survivors (S) compared
with non-survivors (NS)
Score S NS Total
0 1 5 6
1+ 3 5 8
2+ 8 5 14
3+ 19 3 21
Total 31 18 49
Figwe 1 Dark-field illumination of moderately differentiated
colonic adenocarcinomas probed for E-cadherin mRNA. (a)
Sample scored I + with accumulated signal only just highlighting
the underlying glandular element. (b) Sample scored 3+ with
intense accumulation of signal obtained over the glandular com-
ponent. This high accumulation of probe naturally leads to
reduced background.
Table [II Tumour grade and E-cadherin score of Dukes stage B
tumours
E-cadherin score
Grade 0 I+ 2+ 3+ Total
Well 1 0 1 1 3
Moderate 4 7 12 16 39
Poor 2 0 0 5 7
Total 7 7 13 22 49
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Fge 2 Survival of patients with Dukes stage B colorectal
carcinomas as related to E-cadherin mRNA expression. Assign-
ment of tumours to I +, 2+ or 3+ category as detailed in the
text.
immunoreactivity in human carcinomas, but only three were
performed using paraffin-embedded material (Dorudi el al.,
1993; Moll et al., 1993; Rasbridge et al., 1993); the remainder
all used frozen tumours (see Takeichi 1993 for review). This
has made it difficult to examine the majority of archival
material. As stringent fixation requirements are necessary for
consistent and reliable E-cadherin immunohistochemistry in
paraffin-embedded tumours (Rasbridge et al., 1993), in situ
hybnidisation constitutes a valuable technique for examining
such material. A fixation method comprising 2.5% phenol
formol saline was introduced at St. Mark's Hospital in 1987,
and this allowed us to analyse tissue processed subsequent to
this date using immunohistochemical staining. However, in
order to obtain extended survival data we had to use archival
material obtained before 1987 and were unable to achieve
reactivity with antibodies. Since the presence of E-cadherin
mRNA has been shown to be a reliable indicator of the
presence of protein (Schipper et al., 1991; Dorudi et al.,
1993) we used in situ hybridisation.
It may well be of interest that four of the five poorly
differentiated tumours examined in this study which dis-
played E-cadherin scores of 3+ were derived from patients
surviving in excess of 5 years. This is particularly true since
high tumour grade is known to be associated with reduced
survival in colorectal cancer (Deans et al., 1993), while
poorly differentiated bowel carcinomas generally exhibit
reduced or absent E-cadherin expression (Dorudi et al., 1993;
Kinsella et al., 1993; Nigam et al., 1993).
It is apparent from our results that low or absent E-
cadherin expression is associated with reduced survival in
patients undergoing curative resections for Dukes stage B
colorectal carcinomas. However, the numbers in this study
are still small and the analysis retrospective. A large prospec-
tive study is necessary before it can be ascertained whether
levels of E-cadherin expression in colorectal tumours can
truly yield independent prognostic information. If these
preliminary findings are confirmed in a prospective study,
they would be of considerable clinical relevance as, at pres-
ent, accurate prediction of the risk of recurrence or meta-
stasis in patients with Dukes stage B cancers is not possible
(Morson, 1990). Clearly, such information would be ex-
tremely valuable in designating these patients to protocols of
adjuvant therapy and might aid in an understanding of the
molecular nature of tumour spread.
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